Mometamax is an otic suspension containing gentamicin sulfate, mometasone furoate monohydrate and clotrimazole for the treatment of otitis externa in dogs caused by susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Pseudomonas spp.[including P. aeruginosa], coagulase-positive staphylococci, Enterococcus faecalis, Proteus mirabilis, and beta-hemolytic streptococci)
Indications
Mometamax is indicated for the treatment of otitis externa in dogs caused by susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Pseudomonas spp. incl. P. aeruginosa, coagulase positive staphylococci, Enterococcus faecalis, Proteus mirabilis, and beta-hemolytic streptococci.)
Benefits
- Once-a-day Treatment You Can Count On.
- Helps promote client compliance to ensure treatment success
- Mometasone furoate monohydrate – Rapidly controls inflammation to reduce related pain and irritation
- 7.7 times more potent than betamethasone.
- New study reports no adrenocortical suppression with topical administration.
- No corticosteroid-related side effects observed in canine clinical trials.
- Clotrimazole
- Documented efficacy against Malassezia pachydermatis
- Gentamicin – Broad-spectrum antibacterial efficacy.
- Highly active against gram-positive and gram-negative bacteria
gentamicin sulfate, mometasone furoate monohydrate, clotrimazole
Each gram of Mometamax Otic Suspension contains gentamicin sulfate, USP equivalent to 3 mg gentamicin base; mometasone furoate monohydrate equivalent to 1 mg mometasone; and 10 mg clotrimazole, USP in a mineral oil-based system containing a plasticized hydrocarbon gel.
Administer once daily for 7 days
4 drops per ear for dogs <30 lbs
8 drops per ear for dogs = or > 30 lbs